POCT Bilirubin
[POCT Bilirubin]
EPTIS Ringversuch Nr. 1143981 | Letze Änderung 2024-05-21 | URL: https://www.eptis.bam.de/pts1143981 https://www.eptis.bam.de/pts1143981
| Name des Anbieters | ||||||||||
| Name des Anbieters | Weqas Weqas | |||||||||
| Ansässig in | United Kingdom | |||||||||
| Sprache(n) | English | |||||||||
| Anmerkungen | Many of the Blood Gas analysers commonly utilised in a Point of Care setting have the facility to monitor serum Bilirubin. The POCT Bilirubin EQA programme is administered as part of the Weqas Clinical Chemistry EQA programme. Four human serum samples are distributed monthly to monitor the performance of Bilirubin assays for both neonates and adults. Four liquid human serum samples are distributed monthly, with a minimum of 48 samples distributed over the year covering the clinically relevant range. The samples consist of a panel of 8 linearly related samples produced from donations from healthy volunteers spiked with conjugated and a mixed isomer source of unconjugated bilirubin. The four samples per distribution allows for the assessment of within laboratory imprecision whilst distribution of the same sample on a number of occasions over the year allows for the assessment of between batch imprecision. This programme is designed to assess laboratory and method performance, including linearity, bias, within and between batch imprecision. Both neonatal and adult reference and pathological ranges are accommodated including challenging samples at clinical treatment thresholds. The samples are suitable for Point of Care testing, including bilirubinometers and Blood Gas analysers. Key Features: - Liquid human serum samples. Panel of samples covering the pathological range for the laboratory assessment of jaundice in neonates and adults. - Programme design assesses both laboratory and method performance, including linearity, bias, within and between batch imprecision. - Suitable for Laboratory analysers, Blood Gas analysers and PoCT devices. - Scoring based on Milan Model 3 performance specification. For more information: https://www.weqas.com/services/poct-eqa/poct-bilirubin/ or contact@weqas.com or contact@weqas.com | |||||||||
| Klassifizierung | ||||||||||
| Produktgruppen |
Health care / medical devices
|
|||||||||
| Prüfgebiete |
Medical analysis
|
|||||||||
| Technische Einzelheiten | ||||||||||
|
||||||||||
| Ringversuchsziele | ||||||||||
| Zielgruppe des Ringversuchs | The Bilirubin EQA programme is designed to assess laboratory and method performance in the laboratory investigation of jaundice for adults and neonates. | |||||||||
| Relevante Rechtsvorschriften oder Normen | ISO/IEC 17043 | |||||||||
| Weitere Ziele | validation of testing methods | |||||||||
| Teilnehmerzahl | ||||||||||
| Anbieter unabhängig überprüft (akkreditiert, benannt, anerkannt) |
Akkreditiert durch UKAS auf der Grundlage von ISO/IEC 17043 |
|||||||||
| Die Durchführung des Ringversuchs ist in Auftrag gegeben durch | ||||||||||
| Kosten | ||||||||||
| Teilnahmegebühr | https://www.weqas.com/participantzone/subscription-charges/ | |||||||||
| Regelmässig durchgeführt | Ja (Frequency: Monthly. Samples: 4 x 1.0mL. ) | |||||||||
| Der Ringversuch wird durchgeführt seit | 1968 | |||||||||
| Kontaktdaten des Anbieters | ||||||||||
| Anbieter | Kontaktperson | |||||||||
|
Weqas
Unit 6, Parc Ty Glas CF14 5DU Cardiff United Kingdom Telefon: 44 (0) 2920 314750 Fax: Web: http://www.weqas.com http://www.weqas.com |
Laura Lloyd-Lewis
Telefon: 44 (0) 29218 32884 Fax: E-Mail: laura.lloyd-lewis@wales.nhs.uk laura.lloyd-lewis@wales.nhs.uk |
|||||||||
Haben Sie einen Fehler entdeckt? Bitte wenden Sie sich an den zuständigen EPTIS Koordinator für United Kingdom,
Mr Savvas Xystouris.
Mr Savvas Xystouris.